SCHEMBL13228993

SCHEMBL13228993

Cc1cc(C)c(B(c2c(C)cc(C)cc2C)c2ccc3ccc4cc(-c5ccccc5)cc5ccc2c3c45)c(C)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.37
CYP3A4 P08684 1/20 0.37
HPGD P15428 1/20 0.37
TSHR P16473 1/20 0.37
HSD17B10 Q99714 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
PSMB5 P28074 2/20 0.35
ESR1 P03372 3/20 0.35
ESR2 Q92731 3/20 0.35
CYP1A2 P05177 2/20 0.35
ERBB2 P04626 1/20 0.35
FYN P06241 1/20 0.35
MAOA P21397 1/20 0.35
ACHE P22303 1/20 0.35
AHR P35869 1/20 0.35
CYP2A6 P11509 1/20 0.33
PTGER4 P35408 1/20 0.31
LMNA P02545 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13228965 0.88 PSMB5 (0.38) ALDH1A1CYP3A4HPGDTSHRHSD17B10
SCHEMBL13228951 0.88 PSMB5 (0.40) ALDH1A1CYP3A4HPGDTSHRHSD17B10
SCHEMBL9927373 0.87 ALDH1A1 (0.50) ALDH1A1CYP3A4HPGDTSHRHSD17B10
SCHEMBL7462964 0.87 ALDH1A1 (0.38) ALDH1A1CYP3A4HPGDTSHRHSD17B10
SCHEMBL24012571 0.87 ALDH1A1 (0.38) ALDH1A1CYP3A4HPGDTSHRHSD17B10
SCHEMBL13228996 0.86 PSMB5 (0.39) ALDH1A1CYP3A4HPGDTSHRHSD17B10
SCHEMBL13228967 0.86 ESR2 (0.34) ALDH1A1CYP3A4HPGDTSHRHSD17B10
SCHEMBL13228966 0.84 PSMB5 (0.37) ALDH1A1CYP3A4HPGDTSHRHSD17B10
SCHEMBL9927378 0.84 ALDH1A1 (0.50) ALDH1A1CYP3A4HPGDTSHRHSD17B10
SCHEMBL26848610 0.83 ALDH1A1 (0.42) ALDH1A1CYP3A4HPGDTSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8729530-B2 Material for light-emitting device and light-emitting device TORAY INDUSTRIES, INC. (JP) 2014-05-20 US disclosed
US-8729530-B2 Material for light-emitting device and light-emitting device TORAY INDUSTRIES, INC. (JP) 2014-05-20 US disclosed
US-20100163852-A1 Material for light-emitting device and light-emitting device TORAY INDUSTRIES, INC. (JP) 2010-07-01 US disclosed
US-20100163852-A1 Material for light-emitting device and light-emitting device TORAY INDUSTRIES, INC. (JP) 2010-07-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100163852-A1 Material for light-emitting device and light-emitting device CRY1, CRY2, S100A10 ALDH1A1 394/4885CYP3A4 104/4885HPGD 1393/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.